- Jul 15, 2024
Introduction
The healthcare sector is vast and ever-evolving. Elite individuals who have worked hard with their innovative thinking, leadership skills and business insight are responsible for major growth of the industry.
Top billionaires showcase a great amount of influence and their ventures are responsible for the future of healthcare.
This infographic looks into the top 10 healthcare billionaires as individuals who have accomplished financial success and contributed in growth of healthcare industry.
Top 10 Billionaires in Healthcare Industry
1. Thomas F. Frist Jr.
- Company Name: HCA Healthcare
- DOB: August 12, 1938
- Net Worth: $26 billion
- Source of Income: Hospitals
A renowned physician and businessman, Thomas F. Frist Jr. is currently the co-founder of HCA Healthcare. He has previously served as a United States Air Force flight surgeon.
2. Carl Cook
- Company Name: Cook Group
- DOB: November 10, 1962
- Net Worth: $10.2 billion
- Source of Income: Medical devices
Carl Cook is presently the CEO of Cook Group. He has worked in France and Germany to set up computers for the company and has also worked in the pacemaker division.
3. Ronda E. Stryker
- Company Name: Stryker Corporation
- DOB: May 1, 1954
- Net Worth: $7.9 billion
- Source of Income: Health products
Known as an heiress, Ronda E. Stryker, one of the top healthcare billionaires, is at present the CEO of Stryker Corporation. She is also a member of the Harvard Medical School board of fellows and the board of trustees of Spelman College.
4. Reinhold D. Schmieding
- Company Name: Arthrex
- DOB: January 3, 1955
- Net Worth: $7.1 billion
- Source of Income: Medical devices
As the present CEO and initial founder of Arthrex, Reinhold D. Schmieding is an industrious and diligent businessman. Arthrex distributes its products to 90+ countries across continents and has subsidiaries all over Europe, including in Germany, Austria, Belgium, England and France.
5. Robert (Bob) W. Duggan
- Company Name: Pharmacyclics
- DOB: April 28, 1944
- Net Worth: $5.9 billion
- Source of Income: Pharmaceuticals
Robert W. Duggan is an American healthcare executive, entrepreneur, biotech executive, educator, philanthropist and human rights activist. He was the former CEO of the biopharmaceutical company Pharmacyclics and the surgical systems maker of Computer Motion.
6. Patrick Soon-Shiong
- Company Name: NantWorks
- DOB: July 29, 1952
- Net Worth: $5.8 billion
- Source of Income: Pharmaceuticals, self-made
Best known as the inventor of Abraxane, Patrik Soon-Shiong is a famous businessman, investor, medical researcher, philanthropist, and transplant surgeon. He is currently the CEO of NantWorks.
7. Ge Li
- Company Name: WuXi AppTec
- DOB: January 1, 1967
- Net Worth: $5.6 billion
- Source of Income: Pharmaceutical ingredients
Presently the Chairman and CEO of WuXi AppTec, Ge Li is an innovative entrepreneur and philanthropist. W. Clark Still and Koji Nakanishi have mentored him. He was sent to China while working as a representative of Pharmacopeia, Inc. to form a joint business venture.
8. Leonard Steven Schleifer, MD, PhD
- Company Name: Regeneron Pharmaceuticals
- DOB: July 7, 1952
- Net Worth: $3.5 billion
- Source of Income: Pharmaceuticals
Leonard Steven Schleifer is a doctor, businessman, co-founder and chief executive officer of Regeneron Pharmaceuticals, a biotechnology company. He is a healthcare billionaire widely known for creating the pharmaceutical products Eylea and COVID-19 antibody therapeutics.
9. Stewart J. Rahr
- Company Name: Kinray
- DOB: February 18, 1946
- Net Worth: $2.8 billion
- Source of Income: Pharmaceutical distribution
Formerly a pharmaceutical distributor, Stewart J. Rahr is an entrepreneur, investor and philanthropist. He expanded his family’s business into a large conglomerate that delivered 2000+ pharmacies with products wholesale.
10. August Troendle, MD
- Company Name: Medpace
- DOB: January 1, 1956
- Net Worth: $1.6 billion
- Source of Income: Pharmaceutical services
Dr. August Troendle has been Medpace’s CEO and Chairman of the Board since he established it. Before that, he worked as a manager at Sandoz (Novartis), a Medical Review Officer in the FDA’s Metabolic and Endocrine Drug Products Division and a director for the following: Coherus BioSciences, Inc., Xenon Pharmaceuticals Inc., LIB Therapeutics LLC, CinCor Pharma Inc. and Cin Rx Pharma LLC.
Conclusion
The prosperity of these healthcare billionaires is not just a result of their innovation and interest in enhancing healthcare but also shows the potential of their work to transform global health outcomes. From pioneering cutting-edge pharmaceuticals to revolutionizing medical devices, their contributions are indisputable.
